Ampio Pharmaceuticals, Inc. (AMPE)
OTCMKTS
· Delayed Price · Currency is USD
0.0021
0.00 (0.00%)
Feb 19, 2025, 3:00 PM EST
Ampio Pharmaceuticals Employees
Ampio Pharmaceuticals had 6 employees as of December 31, 2023. The number of employees decreased by 2 or -25.00% compared to the previous year.
Employees
6
Change (1Y)
-2
Growth (1Y)
-25.00%
Revenue / Employee
n/a
Profits / Employee
-$1,438,667
Market Cap
2.38K
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 2,931 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
CytoDyn | 9 |
Northwest Biotherapeutics | 25 |
SANUWAVE Health | 31 |
Silence Therapeutics | 109 |
Ampio Pharmaceuticals News
- 11 months ago - Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation - PRNewsWire
- 11 months ago - Ampio Announces Voluntary Delisting and SEC Deregistration - PRNewsWire
- 1 year ago - Ampio Provides Update on Results from Pre-IND Enabling Studies - PRNewsWire
- 1 year ago - Ampio Provides Litigation Update - Reports Settlement in Principle of Certain Pending Legal Actions - PRNewsWire
- 1 year ago - Ampio Pharmaceuticals to Present at the Emerging Growth Conference - PRNewsWire
- 1 year ago - Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201 - PRNewsWire
- 1 year ago - Ampio Pharmaceuticals Announces Reverse Stock Split - PRNewsWire
- 1 year ago - Ampio Pharmaceuticals Announces Series D Preferred Stock Dividend to its Holders of Common Stock - PRNewsWire